GATA2 DEFICIENCY

Clinical trials for GATA2 DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new GATA2 DEFICIENCY trials appear

Sign up with your email to follow new studies for GATA2 DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

New drug could make stem cell transplants safer for rare immune disorder

Disease control Ongoing

This phase II trial tests whether a new drug called Briquilimab can make stem cell transplants safer for people with GATA2 deficiency, a rare genetic condition that weakens the immune system and raises the risk of infections and blood cancers. The study involves 13 participants a…

Matched conditions: GATA2 DEFICIENCY

Phase: PHASE2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

GATA2 DEFICIENCY

Get alerted when new GATA2 DEFICIENCY trials appear

New drug could make stem cell transplants safer for rare immune disorder